Peripheral Facial Palsy Clinical Trial
Official title:
Effect of Stellate Ganglion Block Combined With Facial Nerve Block on the Treatment of Idiopathic Facial Paralysis
NCT number | NCT04800666 |
Other study ID # | 202103102 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | March 1, 2021 |
Est. completion date | March 30, 2022 |
Verified date | November 2022 |
Source | Yangzhou University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Peripheral facial palsy is caused by damage to the facial nerve at any site of the peripheral branches after the facial nucleus.Stellate ganglion block is performed to treat peripheral facial palsy because it increases blood flow and promotes nerve regeneration.Facial Nerve Block worked with elimination of local inflammation of nerve and oppression. Facial nerve block is a treatment that inject drugs into the damaged nerve around to eliminate local inflammation and compression of the nerve.
Status | Completed |
Enrollment | 80 |
Est. completion date | March 30, 2022 |
Est. primary completion date | March 30, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 75 Years |
Eligibility | Inclusion Criteria: Diagnosed by clinical and neurological assessment as one-sided simple facial - Age 18 to 75 years - HBGS above ? - the course of IFP not over 7 days. Exclusion Criteria: - Coagulation dysfunction - plate plate plate shape, quantity or abnormal function - mental system diseases - Gillan-Bahrain syndrome - cancer, mumps, shingles infection, jaw facial pus lymph nodeitis, encephalitis, -cerebral hemorrhage and other diseases - local infection or systemic infectious disease at the puncture site - can not accept to nerve block |
Country | Name | City | State |
---|---|---|---|
China | the Affiliated Hospital of Yangzhou University | Yangzhou | Jiangsu |
Lead Sponsor | Collaborator |
---|---|
Zhuan Zhang |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change from Baseline House-Brackmann | The House-Brackmann scale is a nerve grading system developed in 1985 by Los Angeles otolaryngologists Dr. John W. House and Dr. Derald E. Brackmann. It is used to characterize the severity of a facial paralysis patient's symptoms. | Baseline ,change from baseline House-Brackmann at 3 days,6 days,9 days,14 days,one month,two month | |
Primary | Change from Baseline Sunnybrook | Sunnybrook is a new facial nerve function of subjective assessment system.It is based on both static and dynamic aspects. | Baseline,change from baseline Sunnybrook at 3 days,6 days,9 days,14 days, one month,two month |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05547152 -
Evaluation of the Effectiveness of Virtual Reality Self-rehabilitation in the Treatment of Facial Paralysis and Synkinesis
|
N/A | |
Recruiting |
NCT06430034 -
Contributions of 3D Photography and Stereophotogrammetry to the Evaluation of Facial Symmetrization by Botulinum Toxin Injections. Study of Facial Symmetry Before and After Botulinum Toxin Injections on the Face of Patients Suffering From Sequellar Peripheral Facial Paralysis
|
||
Recruiting |
NCT05191719 -
Neurotomy to Treat Synkinesis Following Peripheral Facial Palsy
|
N/A |